Purpose In the last decade, the research community has focused on defining reliable
biomarkers for the early detection of Alzheimer's disease (AD) pathology. In 2017, the …

We performed a systematic review of studies focusing on the automatic prediction of the
progression of mild cognitive impairment to Alzheimer's disease (AD) dementia, and a …

The aim of this study was to evaluate the accuracy of neuropsychological assessment in
predicting conversion from subjective cognitive decline (SCD) and mild cognitive impairment …

Objective We evaluated the value of resting-state EEG source biomarkers to characterize
mild cognitive impairment (MCI) subjects with an Alzheimer's disease (AD)-like …

Background: Pause duration analysis is a common feature in the study of discourse in
Alzheimer's disease (AD) since this patient group has shown a consistent trend for longer …

Purpose To know whether mild cognitive impairment (MCI) patients will develop Alzheimer's
disease (AD) dementia in very short time or remain stable is of crucial importance, also …

Objective: Neuropsychological assessment (NPA) addresses important aspects of
diagnosis, prognosis, treatment, and rehabilitation planning. This review set out to determine …

Background: Patients with amnestic mild cognitive impairment (aMCI) have an increased
risk of dementia. However, conversion rate varies. Therefore, predicting the dementia …

Co-existence of Alzheimer's disease (AD) in normal pressure hydrocephalus (NPH) is a
frequent finding, thus a common pathophysiological basis between AD and NPH has been …

Amnestic mild cognitive impairment (aMCI) and Type 2 diabetes mellitus (T2DM) are both
important risk factors for Alzheimer's disease (AD). We aimed to investigate whether a T2DM …